Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Hims and Hers (HIMS) PT Lowered to $18 at Jefferies
August 7, 2024 10:16 AM EDTJefferies analyst Glen Santangelo lowered the price target on Hims and Hers (NYSE: HIMS) to $18.00 (from $23.00) while maintaining a Hold rating.
The analyst comments "We are updating our model following 2Q results and management's initial commentary on GLP-1s. We are raising our revenue... More
Hims and Hers (HIMS) PT Raised to $23 at Deutsche Bank
August 6, 2024 4:22 PM EDTDeutsche Bank analyst George Hill raised the price target on Hims and Hers (NYSE: HIMS) to $23.00 (from $16.00) while maintaining a Hold rating.
The analyst comments "Positioned to Grow Specialty Platform: HIMS reported a Q2 beat on a broad basis AMC on Monday where the GLP-1 opportunity in the near term was the overwhelming focus of the earnings call. Since the company... More
